Reply: RE: Reyes A, Révil C, Niggli M, et al. Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Curr Med Res Opin. 2019;35(12):2079-2087.

Curr Med Res Opin

F. Hoffmann-La Roche, Basel, Switzerland.

Published: July 2020

Download full-text PDF	Source
http://dx.doi.org/10.1080/03007995.2020.1744550	DOI Listing

Publication Analysis

reply reyes

reyes révil

révil niggli

niggli et al

et al efficacy

efficacy emicizumab

emicizumab prophylaxis

prophylaxis versus

versus factor

factor viii

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!